Today: 30 April 2026

Nebius Group N.V. (NBIS) Stock on December 8, 2025: Latest News, Price Targets and AI Cloud Growth Forecasts

Nebius Group N.V. (NBIS) Stock on December 8, 2025: Latest News, Price Targets and AI Cloud Growth Forecasts

Nebius Group shares traded just under $100 on December 8, 2025, valuing the company in the mid-$20 billion range. Invesco and StoneX Group disclosed increased stakes, with institutions now holding about 21.9% of the float. The stock remains up over 200% year-to-date despite a 30% pullback since October. New contracts with Microsoft and Meta total over $20 billion, but Morningstar initiated coverage with a $70 fair value.
8 December 2025
··
Netflix’s Warner Bros Takeover: How the $82.7 Billion Deal Could Rewrite the Film Market and Movie Distribution

Netflix’s Warner Bros Takeover: How the $82.7 Billion Deal Could Rewrite the Film Market and Movie Distribution

Netflix announced a deal on Dec. 5, 2025, to buy Warner Bros.’ studio and streaming assets for $82.7 billion, excluding cable networks, which will become a separate company. Three days later, Paramount Skydance made a $108.4 billion hostile bid for all of Warner Bros. Discovery. WBD’s board says it remains committed to Netflix while reviewing the rival offer. The sale would be the largest in Hollywood history if approved.
8 December 2025
··
Fluence Energy (FLNC) Stock Today: Downgrades Hit High-Flying Battery Storage Play – Latest News, Price Targets and Forecasts

Fluence Energy (FLNC) Stock Today: Downgrades Hit High-Flying Battery Storage Play – Latest News, Price Targets and Forecasts

Fluence Energy shares fell about 7–8% intraday on December 8 after Mizuho and Johnson Rice downgraded the stock, citing valuation and execution risks. The drop followed a sharp rally, with the stock still up over 30% year-to-date and trading near $22. The company reported $2.3 billion in fiscal 2025 revenue and announced a new UK battery project milestone. Wall Street consensus targets imply significant downside from current levels.
8 December 2025
··
Marvell Technology (MRVL) Stock Tumbles on Amazon and Microsoft Fears as AI Growth Story Gets Re‑Priced

Marvell Technology (MRVL) Stock Tumbles on Amazon and Microsoft Fears as AI Growth Story Gets Re‑Priced

Marvell Technology shares fell as much as 10% intraday on December 8 after Benchmark downgraded the stock, citing likely losses of Amazon’s Trainium 3 and 4 chip designs and concerns Microsoft could shift custom silicon work to Broadcom. The stock closed about 7% lower at $92.61. Zacks, meanwhile, upgraded Marvell to “Strong Buy” the same day, citing rising earnings estimates.
8 December 2025
···
IREN Limited (NASDAQ: IREN) Stock Update: Microsoft $9.7B AI Deal, Capital Raise and Wall Street Forecasts – December 8, 2025

IREN Limited (NASDAQ: IREN) Stock Update: Microsoft $9.7B AI Deal, Capital Raise and Wall Street Forecasts – December 8, 2025

IREN Limited shares traded near $45 on December 8, down sharply from highs but up over 360% year-to-date after a surge driven by AI and Bitcoin momentum. The company secured a major Microsoft cloud contract and raised billions in new capital, fueling volatility. Market cap stands at about $12.7 billion. Shares fell 16% after the capital raise and dropped 21% in November amid broader sector concerns.
8 December 2025
···
SMX Stock Plunges After 500% Weekly Surge: What Security Matters’ December 8 Sell-Off, New Partnerships and 2025 Forecasts Really Mean

SMX Stock Plunges After 500% Weekly Surge: What Security Matters’ December 8 Sell-Off, New Partnerships and 2025 Forecasts Really Mean

SMX (NASDAQ: SMX) shares plunged over 55% to around $141 by early afternoon on December 8, following a multi-day surge that saw the stock hit $331.98 Friday. Trading volume spiked to 740,000 shares, dwarfing the company’s tiny free float. SMX issued several partnership press releases during the selloff. The stock remains up more than 500% week-on-week but is still down over 98% year-on-year.
8 December 2025
··
Caterpillar Stock (NYSE: CAT): Price, Bobcat Lawsuits, Autonomous Truck Deal and 2025–2026 Forecast – December 8, 2025

Caterpillar Stock (NYSE: CAT): Price, Bobcat Lawsuits, Autonomous Truck Deal and 2025–2026 Forecast – December 8, 2025

Caterpillar shares traded at $595–600 on December 8, down 1% after a 66% year-to-date surge. Doosan Bobcat filed new patent lawsuits seeking an import ban on some Caterpillar equipment. The company announced a major autonomous-truck deal with Vale. Options data show large traders turning more cautious after the rally.
8 December 2025
···
CrowdStrike (CRWD) Stock News Today: Q3 2026 Earnings Beat, AWS Awards and Wall Street Forecasts Into 2026

CrowdStrike (CRWD) Stock News Today: Q3 2026 Earnings Beat, AWS Awards and Wall Street Forecasts Into 2026

CrowdStrike shares traded near $518.54 midday Monday, up 1.27%, after reporting Q3 revenue of $1.23 billion, up 22% year over year, and record annual recurring revenue of $4.92 billion. Non-GAAP net income reached $245.4 million, while GAAP net loss widened to $34 million. Market cap stood at $130.7 billion. The stock remains down 5.2% over the past month.
8 December 2025
··
Warby Parker (WRBY) Stock Soars on Google AI Glasses Timeline: Price Action, Earnings and 2026 Forecasts as of December 8, 2025

Warby Parker (WRBY) Stock Soars on Google AI Glasses Timeline: Price Action, Earnings and 2026 Forecasts as of December 8, 2025

Warby Parker shares surged nearly 15% to $21.51 on December 8 after new disclosures confirmed a 2026 launch of AI-powered smart glasses with Google under the Android XR platform. Trading volume spiked above average, pushing the stock about 58% above its 52-week low. Google has committed up to $150 million to the partnership. Warby Parker’s year-to-date stock performance remains down 26% despite the rally.
8 December 2025
··
Arrowhead Pharmaceuticals (ARWR) Soars to Fresh Highs on Alzheimer’s Trial and FDA Breakthrough Wins

Arrowhead Pharmaceuticals (ARWR) Soars to Fresh Highs on Alzheimer’s Trial and FDA Breakthrough Wins

Arrowhead Pharmaceuticals shares jumped 14–15% intraday on 8 December 2025, reaching a 52-week high near $69 after dosing the first subjects in its Alzheimer’s trial ARO-MAPT. The stock has returned about 270% year-to-date, with a market cap around $9–9.6 billion. The Phase 1/2a trial targets tau protein using Arrowhead’s RNAi platform. Liquidity ratios stand near 4.8, with beta between 1.3 and 1.5.
8 December 2025
·
MercadoLibre (MELI) Stock Today: December 8, 2025 Update on Price, Q3 Results, Bond Deal and Analyst Forecasts

MercadoLibre (MELI) Stock Today: December 8, 2025 Update on Price, Q3 Results, Bond Deal and Analyst Forecasts

MercadoLibre shares traded around $2,080–2,100 on December 8, 2025, with a market cap near $105–108 billion, down 15.6% over six months. The company’s operating margin slipped to 9.8% in Q3 as costs rose. Wall Street remains broadly bullish, and the firm closed a $750 million bond offering. Short interest is low at 1.15% of float.
8 December 2025
··
Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics shares jumped about 20% to $21.70 intraday on December 8, 2025, after new Phase 1 data for its BTK degrader bexobrutideg (NX-5948) in blood cancers was presented at the ASH Annual Meeting. The company reported an 83% response rate in relapsed/refractory CLL/SLL patients and scheduled a webcast for the evening. Volume was well above normal, with shares trading near a 52-week high.
8 December 2025
··
Carvana (CVNA) Soars on S&P 500 Inclusion: Latest News, Stock Forecast and Analysis as of December 8, 2025

Carvana (CVNA) Soars on S&P 500 Inclusion: Latest News, Stock Forecast and Analysis as of December 8, 2025

Carvana shares jumped about 14% to $454 on December 8 after S&P Dow Jones Indices said the company will join the S&P 500 on December 22. The stock is up over 115% in 2025 and has surged more than 8,000% since 2022 lows. Carvana’s market value now stands near $87 billion, surpassing Ford and GM. Index funds are expected to buy shares ahead of the inclusion.
8 December 2025
··
Kymera Therapeutics (KYMR) Stock Soars on KT‑621 Eczema Data: What December 8, 2025 Means for Investors

Kymera Therapeutics (KYMR) Stock Soars on KT‑621 Eczema Data: What December 8, 2025 Means for Investors

Kymera Therapeutics shares jumped nearly 50% Monday, closing near $96 after hitting an intraday high above $100, following strong Phase 1b results for its oral STAT6 degrader KT‑621 in atopic dermatitis. The trial showed about 98% median STAT6 degradation in blood and 94% in skin lesions. Trading volume was far above normal. Stifel raised its price target as the stock marked a new 52-week high.
8 December 2025
··
Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough – What the New Data and Wall Street Forecasts Signal

Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough – What the New Data and Wall Street Forecasts Signal

Wave Life Sciences shares soared as much as 140% Monday after reporting positive interim Phase 1 data for its obesity drug WVE-007. The stock hit $17–18 intraday on record volume topping 100 million shares, up from Friday’s $7.49 close. The trial showed a 9.4% drop in visceral fat and a 3.2% gain in lean mass at three months. Wave’s market value rose to about $2.5–3.0 billion.
8 December 2025
·
Confluent (CFLT) Soars on IBM’s $11 Billion Takeover: Deal Terms, Stock Outlook and Analyst Forecasts After December 8, 2025 Rally

Confluent (CFLT) Soars on IBM’s $11 Billion Takeover: Deal Terms, Stock Outlook and Analyst Forecasts After December 8, 2025 Rally

IBM will acquire Confluent for $31 per share in cash, valuing the company at about $11 billion. Confluent stock jumped nearly 29% on December 8, trading close to the buyout price after the deal was announced. Both boards approved the agreement, with major shareholders backing the transaction. Closing is expected by mid-2026, pending shareholder and regulatory approval.
8 December 2025
···
Banco Bradesco (BBD) Stock on December 8, 2025: Is the Post‑Earnings Sell‑Off a Buying Opportunity?

Banco Bradesco (BBD) Stock on December 8, 2025: Is the Post‑Earnings Sell‑Off a Buying Opportunity?

Banco Bradesco ADRs traded near $3.35 on December 8, 2025, recovering slightly after a 9% drop on December 5. Q3 net income rose 18.8% year-on-year to R$6.2 billion, but earnings per share missed estimates, triggering the selloff. Hedge funds cut stakes in Q2 while Fisher Asset Management raised its position. Analysts maintain a consensus “Buy” rating with 12-month targets between $2.40 and $3.72.
8 December 2025
··
Boeing (BA) Stock Today: Spirit AeroSystems Deal Closes as Wall Street Sees Double‑Digit Upside

Boeing (BA) Stock Today: Spirit AeroSystems Deal Closes as Wall Street Sees Double‑Digit Upside

Boeing closed its $4.7 billion takeover of Spirit AeroSystems on December 8, 2025, bringing 15,000 Spirit employees under its control and reclaiming key fuselage facilities. Boeing shares rose about 2% to $206, lifting its market value to the mid-$150 billion range. The deal follows improved 2026 guidance and new “Buy” ratings from Wall Street. Regulators approved the acquisition after Boeing agreed to divest certain assets.
8 December 2025
···
1 … 1,295 1,296 1,297 1,298 1,299 … 1,882

Stock Market Today

  • ASX set to slide as oil prices jump over $120 a barrel
    April 29, 2026, 6:07 PM EDT. The Australian share market (ASX) is expected to open lower, with futures down 0.8% to 8,627 points, following mixed results on Wall Street. The Dow Jones fell 0.6%, S&P 500 slipped 0.04%, while the Nasdaq rose 0.6%. European markets also declined, led by the FTSE down 1.2%. Oil prices surged 8.7% to over $US120 a barrel, driven by Brent crude hitting $US120.92. Commodities like iron ore rose 0.6%, while precious metals and the Australian dollar weakened. This sharp oil price increase pressures markets and is a key factor behind the ASX's anticipated drop. The market will be closely watching further economic and commodity developments throughout the trading day.

Latest article

Microsoft Stock Falls After Earnings Beat as Azure Growth Hits 40% and AI Revenue Surges

Microsoft Stock Falls After Earnings Beat as Azure Growth Hits 40% and AI Revenue Surges

29 April 2026
Microsoft reported fiscal Q3 revenue of $82.9 billion, up 18%, and net income of $31.8 billion, up 23%, beating analyst estimates. Azure revenue jumped 40%, and AI business annual run rate hit $37 billion, up 123%. Shares fell over 2% after hours as investors focused on rising capital expenditures, which climbed 49% to $31.9 billion. Free cash flow dropped to $15.8 billion from $20.3 billion a year earlier.
Meta Stock Slides as $145 Billion AI Spending Plan Overshadows Blowout Earnings

Meta Stock Slides as $145 Billion AI Spending Plan Overshadows Blowout Earnings

29 April 2026
Meta Platforms shares dropped about 5% in after-hours trading Wednesday after the company raised its 2026 capital spending forecast to $125–$145 billion. First-quarter revenue rose 33% to $56.31 billion, beating estimates, while net income reached $26.77 billion, boosted by an $8.03 billion tax benefit. Meta expects second-quarter revenue of $58–$61 billion. Daily active users across its apps increased 4% to 3.56 billion.
Chipotle Stock Jumps After Chicken Bet Breaks Its Sales Slump

Chipotle Stock Jumps After Chicken Bet Breaks Its Sales Slump

29 April 2026
Chipotle Mexican Grill reported a 0.5% rise in first-quarter comparable sales, reversing recent declines and beating analyst expectations. Total revenue rose 7.4% to $3.09 billion, while shares jumped 7% in after-hours trading. Operating margin narrowed to 12.9% from 16.7% a year earlier. Menu items like Chicken al Pastor and Honey Chicken drove increased restaurant visits.
Go toTop